C. Sahlmann

966 total citations
25 papers, 732 citations indexed

About

C. Sahlmann is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Sahlmann has authored 25 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Sahlmann's work include Radiopharmaceutical Chemistry and Applications (7 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Hematological disorders and diagnostics (5 papers). C. Sahlmann is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Hematological disorders and diagnostics (5 papers). C. Sahlmann collaborates with scholars based in Germany. C. Sahlmann's co-authors include J. Meller, U. Siefker, Frank Strutz, R. Vosshenrich, Mark F. Conrad, Alexander Scheel, K. Lehmann, Birgit Meller, Lutz Trojan and Sameh Hijazi and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging and The Prostate.

In The Last Decade

C. Sahlmann

23 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Sahlmann Germany 10 537 207 192 169 117 25 732
Joerg Kotzerke Germany 14 209 0.4× 371 1.8× 37 0.2× 287 1.7× 45 0.4× 27 853
Carmelo Caldarella Italy 16 299 0.6× 189 0.9× 44 0.2× 354 2.1× 47 0.4× 55 773
Nasrin Ghesani United States 11 192 0.4× 108 0.5× 31 0.2× 158 0.9× 68 0.6× 35 503
Hueisch‐Jy Ding Taiwan 14 239 0.4× 318 1.5× 66 0.3× 190 1.1× 19 0.2× 37 694
Soma Mohammed Australia 19 97 0.2× 80 0.4× 152 0.8× 272 1.6× 97 0.8× 58 1.1k
Karen De Amorim Bernstein United States 16 345 0.6× 73 0.4× 137 0.7× 143 0.8× 44 0.4× 31 681
Fritz Kammerhuber Austria 12 224 0.4× 215 1.0× 71 0.4× 438 2.6× 16 0.1× 17 752
Seiji Kurata Japan 15 192 0.4× 256 1.2× 41 0.2× 109 0.6× 25 0.2× 50 586
Michael B. Brachman United States 13 216 0.4× 215 1.0× 51 0.3× 219 1.3× 14 0.1× 28 627
Elżbieta Wiatr Poland 15 431 0.8× 24 0.1× 99 0.5× 90 0.5× 275 2.4× 119 722

Countries citing papers authored by C. Sahlmann

Since Specialization
Citations

This map shows the geographic impact of C. Sahlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sahlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sahlmann more than expected).

Fields of papers citing papers by C. Sahlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sahlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sahlmann. The network helps show where C. Sahlmann may publish in the future.

Co-authorship network of co-authors of C. Sahlmann

This figure shows the co-authorship network connecting the top 25 collaborators of C. Sahlmann. A scholar is included among the top collaborators of C. Sahlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Sahlmann. C. Sahlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
König, Frank, Arne Strauß, Manfred Johannsen, et al.. (2019). Radium-223 zur Therapie des metastasierten kastrationsresistenten Prostatakarzinoms (mCRPC). Der Urologe. 59(1). 53–64. 1 indexed citations
2.
Bouter, Caroline, et al.. (2016). 18F-FDG-PET/CT bei erhöhten Entzündungsparametern unklarer Genese – eine Zusammenführung verschiedener Entitäten. Nuklearmedizin - NuclearMedicine. 55(6). 242–249. 1 indexed citations
3.
Sahlmann, C. & Philipp Ströbel. (2016). Pathophysiologie der Entzündung. Nuklearmedizin - NuclearMedicine. 55(1). 1–6. 7 indexed citations
4.
Meller, Birgit, Felix Bremmer, C. Sahlmann, et al.. (2015). Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy. EJNMMI Research. 5(1). 66–66. 117 indexed citations
5.
Hüfner, M., et al.. (2013). Wie verlässlich ist die sekundäre Risikostratifizierung mittels stimulierten Thyreoglobulins bei Patienten mit differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 52(3). 88–96. 2 indexed citations
6.
Homayounfar, Kia, Annalen Bleckmann, Lena‐Christin Conradi, et al.. (2013). Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival. International Journal of Colorectal Disease. 28(7). 1009–1017. 17 indexed citations
7.
Hüfner, M., et al.. (2013). How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma?. Nuklearmedizin - NuclearMedicine. 52(3). 88–96. 3 indexed citations
8.
Sahlmann, C., et al.. (2012). Patienten mit Autoimmunthyroiditis – Prävalenz der gutartigen Lymphadenopathie. Nuklearmedizin - NuclearMedicine. 51(6). 223–227. 4 indexed citations
9.
Homayounfar, Kia, Annalen Bleckmann, Lena‐Christin Conradi, et al.. (2012). Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. International Journal of Colorectal Disease. 27(10). 1359–1367. 13 indexed citations
10.
Meller, J., et al.. (2012). Patients with autoimmune thyroiditis. Nuklearmedizin - NuclearMedicine. 51(6). 223–227. 9 indexed citations
11.
Meller, J., et al.. (2010). Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs).. PubMed. 54(6). 582–98. 9 indexed citations
12.
Meller, J., et al.. (2009). FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis.. PubMed. 53(1). 51–63. 43 indexed citations
13.
14.
Schindler, Christoph, et al.. (2007). 22-jährige Frau mit Fieber, Nachtschweiß, Gewichtsverlust und Hepatomegalie. Der Internist. 48(8). 863–869. 1 indexed citations
15.
Sahlmann, C., U. Siefker, H. Luig, et al.. (2006). [Improvement of tomographic reconstruction in bone SPECT].. PubMed. 45(1). 35–40. 1 indexed citations
16.
Füzesi, L., Joachim Struck, U. Siefker, et al.. (2005). Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence.. PubMed. 44(3). 86–93. 5 indexed citations
17.
18.
Meller, J., Frank Strutz, U. Siefker, et al.. (2003). Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging. 30(5). 730–736. 335 indexed citations
19.
Angerstein, C., U. Siefker, Kurt Lehmann, et al.. (2003). Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma. Nuklearmedizin - NuclearMedicine. 42(2). 71–77. 4 indexed citations
20.
Meller, J., G. Altenvoerde, K. Lehmann, C. Sahlmann, & W. Becker. (2001). 19. Fever of unknown origin: prospective comparison of 18F-FDG imaging with a double head coincidence camera and 67Ga citrate SPECT. Nuclear Medicine Communications. 22(10). 1158–1159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026